Hematology, Oncology & Immunology · Topic 3 of 26
Sickle Cell Disease: Acute Complications
Sickle Cell Disease: Acute Complications
Treat pain within an hour, hunt for acute chest syndrome, treat fever as sepsis, and transfuse within 2 hours for any new neurologic deficit.
For a vaso-occlusive crisis, give analgesia within 1 hour of ED arrival and reassess every 30–60 minutes; treat severe pain with parenteral opioids dosed on the home regimen and prior effective therapy.
Acute chest syndrome = a new pulmonary infiltrate with fever, chest pain or respiratory symptoms (cough, tachypnea, hypoxemia); it may follow pneumonia or a pain crisis and is the leading cause of sickle cell deaths.
A new focal neurologic deficit or TIA in sickle cell disease needs transfusion within 2 hours of presentation — simple or exchange by hemoglobin and local resources — without waiting for imaging or consultants.
Do right now
In this orderWhy each step
Management
OrdersRed flags & don'ts
Avoid harmThe rules
Know theseSimple or exchange transfusion?
Commonly confused| Goal | Raise hemoglobin and oxygen-carrying capacity |
|---|---|
| Typical use | Aplastic crisis; symptomatic ACS with Hb > 1 g/dL below baseline |
| Stroke or TIA | Low Hb, or exchange not possible within 2 h |
| Hemoglobin ceiling | Do not exceed 10 g/dL (hyperviscosity) |
More detail
ReferenceShow 7 reference facts
Pain, fever, chest, brain: every acute sickle cell visit is screened for all four — and acute chest syndrome is the one that kills.
Sources · Merck Manual Professional — Sickle Cell Disease · Brandow AM et al. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv 2020;4:2656–2701 (PMC7322963) · Chou ST et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020;4:327–355 (PMC6988392) · DeBaun MR et al. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv 2020;4:1554–1588 (PMC7189278) · ASH educational slide set — Managing Cerebrovascular Disease (ASH 2020 SCD guidelines): transfuse within 2 h; exchange if Hb > 8.5 g/dL; tPA must not delay transfusion · NHLBI. Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014 · Yawn BP et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 2014;312:1033–1048 · Merck Manual Professional — Complications of Transfusion (delayed hemolytic transfusion reaction) · ASH — 2020 SCD Guidelines: Cerebrovascular Disease snapshot (simple transfusion without delaying for consults or brain imaging) · MDedge/The Hospitalist — Clinical guideline highlights: ASH 2020 SCD acute and chronic pain (Rec 1: analgesia within 1 hour, reassess every 30–60 min; Rec 3: NSAIDs 5–7 days) · ASH educational slide set — Transfusion Support (ASH 2020 SCD guidelines): RCE for severe ACS; preop transfusion for anesthesia > 1 h; immunosuppression for DHTR/hyperhemolysis · ASH educational slide set — Management of Acute and Chronic Pain (ASH 2020 SCD guidelines): ketamine 0.1–0.3 mg/kg/h, max 1 mg/kg/h · Starter sheet built from the verified AGACNP fact map (facts reviewed 2026-10-15).